Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage i non-small cell lung cancer
Research output: Contribution to journal › Article › peer-review
11Scopus
citations
Fingerprint
Dive into the research topics of 'Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage i non-small cell lung cancer'. Together they form a unique fingerprint.